Ioxilan. Initial clinical observations.
Callantine
M R
MR
Biophysica Foundation, La Jolla, California.
Sovak
M
M
Lu
H P
HP
D000328:Adult; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D004341:Drug Evaluation; D004361:Drug Tolerance; D006801:Humans; D007275:Injections, Intravenous; D007472:Iohexol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D008297:Male; D008875:Middle Aged; D012449:Safety
D003287:Contrast Media; D007472:Iohexol; C055357:ioxilan